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Abstract
Background: We aimed to determine the effect of feeding transgenic maize to sows during gestation and lactation on
maternal and offspring immunity and to assess the fate of transgenic material.
Methodology/Principal Findings: On the day of insemination, sows were assigned to one of two treatments (n = 12/
treatment); 1) non-Bt control maize diet or 2) Bt-MON810 maize diet, which were fed for ,143 days throughout gestation
and lactation. Immune function was assessed by leukocyte phenotyping, haematology and Cry1Ab-specific antibody
presence in blood on days 0, 28 and 110 of gestation and at the end of lactation. Peripheral-blood mononuclear cell
cytokine production was investigated on days 28 and 110 of gestation. Haematological analysis was performed on offspring
at birth (n = 12/treatment). Presence of the cry1Ab transgene was assessed in sows’ blood and faeces on day 110 of
gestation and in blood and tissues of offspring at birth. Cry1Ab protein presence was assessed in sows’ blood during
gestation and lactation and in tissues of offspring at birth. Blood monocyte count and percentage were higher (P,0.05),
while granulocyte percentage was lower (P,0.05) in Bt maize-fed sows on day 110 of gestation. Leukocyte count and
granulocyte count and percentage were lower (P,0.05), while lymphocyte percentage was higher (P,0.05) in offspring of
Bt maize-fed sows. Bt maize-fed sows had a lower percentage of monocytes on day 28 of lactation and of CD4+CD8+
lymphocytes on day 110 of gestation, day 28 of lactation and overall (P,0.05). Cytokine production was similar between
treatments. Transgenic material or Cry1Ab-specific antibodies were not detected in sows or offspring.
Conclusions/Significance: Treatment differences observed following feeding of Bt maize to sows did not indicate
inflammation or allergy and are unlikely to be of major importance. These results provide additional data for Bt maize safety
assessment.
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Introduction
The continuous increase in the area cultivated with genetically
modified (GM) crops [1] and consequently their ubiquitous
presence makes it increasingly difficult for consumers to avoid
GM products. However, the dispute regarding the safety of GM
crops is far from resolved [2] and consumer opinions vary over
time and from country to country [3,4].
Bt MON810 maize is resistant to attack by Lepidopterae pests, as
it expresses the Cry1Ab protein [5]. This protein is produced in all
plant tissues as a result of introduction of the bacterial cry1Ab
transgene into the maize genome [6]. While the bacterial Cry1Ab
protein has been extensively used as an organic insecticide [7], its
expression in transgenic maize could potentially alter its structure
which may render it allergenic or otherwise harmful upon
ingestion [8]. Fears are expressed by consumers regarding the
safety of transgenic compounds following long-term consumption
[9,10]. As pregnancy-related hormonal changes may result in
immunosuppression [11,12], the immune system of pregnant
females may respond differently to dietary antigens. Maize is a
major component of animal feed and the safety of feeding GM
maize to breeding livestock is also of paramount importance.
Having been marketed in the US since 1996 and grown in
market penetration since then [1] with no evidence to suggest
harmful effects, Bt MON810 maize has a relatively long history of
safe use [13]. Furthermore, numerous controlled studies have
investigated the effects of dietary Bt maize in different animal
species [14]. However, while several studies have investigated
effects over multiple generations in rodents and ruminants [15],
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multi-generational studies in pigs are notably lacking from the
literature. It is well known that the digestive physiology of pigs is
very similar to that of humans [16–18]. Therefore, studies in pigs
may provide some insight into the expected effects of trans-
generational Bt maize consumption in humans, although the
limitations of any animal model must always be taken into
account.
The aim of the present study was to investigate the effects of
feeding Bt MON810 maize to nulliparous sows during pregnancy
and lactation on maternal and offspring immune function and to
assess the presence of transgenic material in the blood of sows as
well as in the blood and tissues of offspring at birth.
Methods
Ethical approval
The pig study complied with European Union Council
Directives 91/630/EEC (outlines minimum standards for the
protection of pigs) and 98/58/EC (concerns the protection of
animals kept for farming purposes) and was approved by, and a
license obtained from, the Irish Department of Health and
Children (license number B100/4147). Ethical approval was
obtained from Teagasc and Waterford Institute of Technology
ethics committees.
Maize and diets
Seeds derived from GM Bt MON810 and non-GM parent line
control maize (PR34N44 and PR34N43, respectively; Pioneer Hi-
Bred, Sevilla, Spain) were grown simultaneously side by side in
2007 in Valtierra, Navarra, Spain by independent tillage farmers.
The Bt and non-Bt control maize were purchased by the authors
from the tillage farmers for use in this animal study.
Diets were manufactured as previously described by Walsh et al.
[19]. All diets were formulated to meet or exceed the National
Research Council requirements for pigs of given weights [20]. The
Bt and non-Bt control maize, as well as the whole diets, were
sampled in accordance with international guidelines [21] and
tested for chemical, carbohydrate and amino acid composition as
well as for presence of pesticide contaminants, the cry1Ab
transgene, and mycotoxins, as previously described by Walsh et
al. [19].
Animals and experimental design
Twenty four sows (Large White 6 Landrace) were purchased
from Hermitage AI (Kilkenny, Ireland) as weanling pigs (,28 days
old) and raised to ,165 kg on diets free of GM ingredients. On
the day of insemination, sows were blocked by body weight and
insemination date and randomly assigned to one of two dietary
treatments: 1) non-Bt control parent line maize diet (Pioneer
PR34N43) or 2) Bt maize diet (Pioneer PR34N44 event
MON810). Sows were fed experimental diets from insemination
throughout gestation and lactation until weaning at ,28 days
post-farrowing (,143 days in total). Diets used in this animal study
are presented in Table 1.
Synchronization of oestrus was achieved by administering
20 mg of altrenogest (RegumateTM, Intervet/Schering-Plough
Animal Health, Bray, Ireland) per gilt in the feed for 18 days. A
sexually mature boar was housed adjacent to the gilts to stimulate
oestrus. Nine days prior to predicted oestrus, the gilts were flush
fed (4 kg/day) gilt developer diet (6.0 g/Kg lysine and 13.67 MJ/
Kg DE). Sows were inseminated with pooled semen from five
Hylean MaxGroTM boars (Hermitage AI) as soon as oestrus was
detected and again 24 h later. Following insemination, sows were
penned in individual gestation stalls (2.4 m60.6 m; O’Donovan
Engineering, Coachford, Ireland) until day 110 of gestation.
Environmental temperature was maintained between 20 and 22uC
and sows were provided with ad libitum access to water from one
drinker per pen (Arato, Ko¨ln, Germany). Supplementary feed was
not offered to suckling piglets.
A vaccine to prevent E. coli neonatal enterotoxicosis in piglets
(Porcoli Diluvac ForteTM; Intervet/Schering-Plough Animal
Health) was administered to all sows on days 74 and 99 of
gestation. ZerofenTM (4% powder, Chanelle Animal Health
Limited, Liverpool, UK) was administered to sows in feed
(0.125 g/kg body weight) on day 110 of gestation for routine
deworming.
From day 110 of gestation until weaning, sows were housed in
three farrowing rooms with 10 farrowing crates (O’Donovan
Engineering) per room. Control and treatment sows were allotted
to farrowing rooms in equal numbers to minimise environmental
influences. However, to minimise potential cross-contamination,
control and treatment sows were penned together on either side of
a central dividing passageway. Room temperature was maintained
at 20uC and increased to 24uC for 48 h around farrowing. Sows
had access to feed from a Daltec feeder (Daltec A/S, Egtved,
Denmark) and were fed 2 kg/day immediately post-farrowing.
Feed allowance was then increased by 500 g/day until day 7 post-
farrowing when sows were offered ad libitum access to feed.
Unlimited access to water was provided throughout lactation via a
single nipple drinker per pen. Induction of farrowing was achieved
by administering 2 mL of EnzaprostTM (5 mg/ml; CEVA Animal
Health Ltd, Chesham Bucks, UK) on day 114 of gestation.
At farrowing, the fourth piglet born alive from each sow was
euthanized before suckling occurred and samples were obtained,
as outlined below.
At all times throughout the study sows were observed closely at
least twice daily and any showing signs of ill health were treated as
appropriate and all veterinary treatments recorded. Data from
these animals was examined on a case by case basis and if
necessary, removed from the data set.
Blood, faeces and tissue sampling
Blood samples were taken from the external jugular vein of sows
at insemination (day 0), at days 28 and 110 of gestation and on day
28 of lactation (n= 12/treatment). Blood samples were also
collected from offspring at birth. Whole blood from sows and
offspring was sampled in K2EDTA evacuated tubes (Vacuette,
Greiner Bio One Ltd, Gloucestershire, UK) and stored at room
temperature for whole blood haematological analysis (within
6 hours of sampling). Haematological analysis was performed
using a Beckman Coulter Ac T Diff analyser (Beckman Coulter
Ltd., High Wycombe, UK) for determination of white blood cell
counts (WBC#) and counts and percentage of lymphocytes (LY#
and LY%), monocytes (MONO# and MONO%) and granulo-
cytes (GRAN# and GRAN%). Calibration of the analyser was
performed in accordance with the manufacturer’s instructions and
accuracy was determined by testing control samples of known
values.
Blood was also collected from sows in evacuated tubes
containing a silica coagulation activator (Vacuette) and allowed
to coagulate for 2 hours at room temperature. Serum was then
collected following centrifugation at room temperature, at 15006g
for 10 minutes. The serum was analysed for presence of the
Cry1Ab protein and its specific antibodies, as outlined below.
White blood cells for gene detection were isolated from sow and
offspring blood collected in K2EDTA evacuated collection tubes.
To prevent DNA degradation, the tubes were stored on ice
following sampling and were centrifuged within 2 hours at 4uC, at
Trans-Generational Effects of Bt Maize in Pigs
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15006g for 10 minutes. The separated plasma from offspring
blood was also collected for Cry1Ab protein detection. White
blood cell and plasma samples were stored at 220uC until
analysed.
Blood samples were also collected from sows in sodium heparin
tubes (BD Vacutainer Systems, Franklin Lakes, NJ, USA) for
isolation of peripheral blood mononuclear cells (PBMC), as
outlined below.
Prior to all blood sampling the skin at the sampling site was
thoroughly swabbed with 70% ethanol to prevent contamination
of blood samples with feed dust.
Colostrum samples for detection of Cry1Ab-specific antibodies
(as outlined below) were collected from sows immediately prior to
parturition in 30 ml sterile containers (Sterilin Limited, Newport,
UK) and stored at 220uC until analysis. Sow teats were sanitised
with 70% ethanol prior to sampling to prevent environmental
contamination.
On day 110 of gestation, faecal samples were collected from
sows and stored at 220uC prior to gene detection (n = 12/
treatment).
The heart, kidney, spleen, liver, semitendinosus muscle, brain and
navel tissue were collected from offspring at birth for Cry1Ab
protein and transgene detection and stored at 220uC until
analysed. Every effort was made to prevent environmental and
cross-contamination; Scalpel blades and gloves were changed and
all instruments were sanitised using 70% ethanol after each pig
was sampled. Furthermore, each organ was placed on a single-use
aluminium foil sheet to avoid cross-contamination and the outer
surface was removed and samples were taken from an inner
portion. In addition, to avoid contamination with feed dust,
sampling of all tissues was performed in a room separate to the
farrowing house.
Immune cell populations and cytokine production
Sow PBMC were isolated and stimulated using a combination
of phorbol 12-myristate 13-acetate and ionomycin on days 28 and
110 of gestation, as described by Walsh et al. [22]. Prior to and
following stimulation, the cell culture supernatant was removed
and stored at 280uC for analysis of cytokines (IL-4, IL-6, IL-8 and
TNF-a). Cytokine concentrations were determined using multi-
plex porcine-specific ELISA kits (Meso Scale Discovery, Gaithers-
burg, MD, USA) in accordance with the manufacturer’s instruc-
tions.
Staining of PBMC with fluorescent antibodies for flow
cytometric analysis was also performed as described by Walsh et
al. [22,23] for determination of the percentages of white blood
cells, B lymphocytes, monocytes and CD3+, CD4+, CD8+ and
CD4+CD8+ T lymphocytes. Proportions of monocytes and B and
T lymphocytes were calculated from the total number of white
blood cells. Proportions of CD4+, CD8+ and CD4+CD8+ T
lymphocytes were calculated from the number of CD3+ T
lymphocytes. These cells were analysed in sows at day 0, 28 and
110 of gestation and at day 28 of lactation using a BD FACSCanto
flow cytometer (BD Biosciences, Franklin Lake, NJ, USA) and
FACSDiva software (BD Biosciences).
Table 1. Composition of diets fed to sows during gestation and lactation (fresh weight basis, %).
Gestation Lactation
Ingredient Non-Bt control Bt Non-Bt control Bt
Maize 86.55 86.55 74.42 74.42
Soybean meal (non-GM) 10.33 10.33 19.30 19.30
Soybean oil - - 3.02 3.02
L-Lysine HCl 0.16 0.16 0.25 0.25
DL-Methionine - - 0.10 0.10
L-Threonine - - 0.06 0.06
Vitamin and mineral premix1 0.10 0.10 0.10 0.10
Salt 0.40 0.40 0.40 0.40
Di-calcium phosphate 1.36 1.36 1.29 1.29
Limestone flour 1.10 1.10 1.06 1.06
Analysed chemical composition
Dry matter 88.40 87.80 89.50 88.60
Crude protein 11.80 11.00 15.60 15.00
Fat 3.00 3.20 5.90 6.00
Crude fibre 1.70 1.60 1.60 1.90
Ash 4.10 4.30 4.60 4.30
Lysine 0.64 0.68 1.01 0.96
Ca2 7.60 7.60 7.50 7.50
P2 6.10 6.10 6.20 6.20
Digestible energy, MJ of DE/kg2 13.80 13.80 14.50 14.50
1Premix provided per kg of complete diet: Cu, 15 mg; Fe, 70 mg; Mn, 62 mg; Zn, 80 mg, I, 0.6 mg; Se, 0.2 mg; retinyl acetate, 3.44 mg; cholecalciferol, 25 mg; DL-alpha-
tocopheryl acetate, 100 mg; vitamin K, 2 mg; vitamin B12, 15 mg; riboflavin, 5 mg; nicotinic acid, 12 mg; pantothenic acid, 10 mg; choline chloride, 500 mg; vitamin B1,
2 mg; and vitamin B6, 3 mg.
2Calculated values.
doi:10.1371/journal.pone.0047851.t001
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Cry1Ab protein and transgene detection in faeces, blood
and tissues
The presence of the Cry1Ab protein in the serum of sows at day
28 and 110 of gestation and day 28 of lactation and in the plasma
and tissues of offspring euthanized at birth was assessed using the
QuantiPlate kit for Cry1Ab/Cry1Ac detection (Envirologix,
Maines, USA) in accordance with the manufacturer’s instructions.
Cry1Ab protein was extracted from serum of sows and from
organs (heart, kidney, spleen, liver, muscle, liver, navel cord and
brain) of pigs euthanized at birth as previously described by Walsh
et al. [24].
Extraction of DNA from sow and offspring white blood cells and
offspring tissues (kidney, liver and muscle) was also conducted as
previously outlined by Walsh et al. [23]. The presence of two
Table 2. Effects of feeding Bt MON 810 maize to nulliparous sows during gestation and lactation on haematological parameters of
sows1.
Treatments
Transformation2 Non-Bt control Bt P – value
Mean 95% CI3 Mean 95% CI3
WBC4,6103/mL 20.5
Day 28 of gestation 20.4 18.3–23.0 21.3 19.0–24.0 0.61
Day 110 of gestation 16.2 14.7–18.0 16.4 14.9–18.3 0.90
Day 28 of lactation 18.0 16.2–20.1 17.8 16.0–19.8 0.83
Overall 18.0 16.9–19.3 18.3 17.1–19.6 0.82
Lymphocytes, % 1.75
Day 28 of gestation 54.3 50.7–57.7 53.5 49.9–57.0 0.76
Day 110 of gestation 46.0 41.9–49.9 49.5 45.7–53.2 0.21
Day 28 of lactation 38.8 34.1–43.1 39.6 34.9–43.9 0.81
Overall 46.7 43.9–49.4 47.8 45.1–50.4 0.55
Monocytes, % 20.5
Day 28 of gestation 5.7 4.4–7.8 5.3 4.1–7.1 0.68
Day 110 of gestation 3.9 3.1–5.0 5.7 4.4–7.8 0.04
Day 28 of lactation 5.2 4.0–6.9 5.8 4.4–7.9 0.57
Overall 4.8 4.2–5.7 5.6 4.8–6.6 0.19
Granulocytes, % none
Day 28 of gestation 40.8 35.6–46.0 40.3 35.1–45.5 0.89
Day 110 of gestation 50.7 45.4–55.8 41.0 35.3–45.8 0.01
Day 28 of lactation 57.7 52.2–63.1 54.3 48.9–59.7 0.39
Overall 49.7 46.3–53.0 45.1 41.7–48.4 0.06
Lymphocytes,6103/mL 0.25
Day 28 of gestation 10.9 10.0–11.9 11.6 10.6–12.7 0.34
Day 110 of gestation 7.3 6.6–8.0 8.2 7.4–9.0 0.09
Day 28 of lactation 7.0 6.3–7.8 7.0 6.3–7.7 0.93
Overall 8.3 7.8–8.8 8.8 8.3–9.3 0.14
Monocytes,6103/mL 20.25
Day 28 of gestation 1.2 0.9–1.6 1.2 0.9–1.6 0.89
Day 110 of gestation 0.6 0.5–0.8 1.0 0.8–1.4 0.03
Day 28 of lactation 0.9 0.7–1.2 1.0 0.8–1.4 0.38
Overall 0.9 0.7–1.0 1.1 0.9–1.3 0.09
Granulocytes,6103/mL 0.5
Day 28 of gestation 8.6 7.0–10.4 8.8 7.2–10.6 0.88
Day 110 of gestation 8.3 6.7–10.0 6.5 5.1–8.0 0.11
Day 28 of lactation 10.4 8.6–12.3 9.7 8.0–11.5 0.57
Overall 9.1 7.9–10.3 8.3 7.2–9.5 0.33
1Sows were fed either a non-Bt control or a Bt maize-based diet (n = 12/treatment).
2Lambda used for Box Cox transformation of data to ensure normal distribution. Means and 95% confidence limits for data which were normalised using the Box Cox
transformation were back transformed and are presented on the original scale.
395% CI –95% confidence interval (the interval that contains the true population mean in 95% of cases).
4WBC – white blood cells.
doi:10.1371/journal.pone.0047851.t002
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cry1Ab transgene fragments (149 and 211 bp), the sw (porcine
growth hormone) gene (108 bp), the shrunken 2 gene (sh2; a maize-
specific ADP glucose pyrophosphorylase gene; 213 bp) and the
rubisco gene (maize-specific ribulose bisphosphate carboxylase; 173
bp) was assessed by PCR as previously described by Walsh et al.
[23,24].
Cry1Ab-specific antibody response
The presence of Cry1Ab protein-specific immunoglobulins (IgA
and IgG) was investigated in the serum at day 28 and 110 of
gestation and day 28 of lactation and colostrum of sows and in the
plasma of the offspring sacrificed at birth, as described by Walsh et
al. [23].
Statistical analysis
Statistical analysis was performed using SAS 9.2 [25]. To ensure
normality, haematology data (except for sow GRAN% and
offspring WBC# and LY# which were initially normally
distributed) were transformed using the Box Cox transformation
[26] x= (yl-1)/l where y is the initial variable and l is a constant
(values of l are presented in Tables 2 and 3). Data which were
initially normally distributed or which were normalised using the
Box Cox transformation were analysed using PROC MIXED,
with treatment and day as fixed effects and block as a random
effect. Day 0 values were used as a covariate in the model and day
was included in the model as a repeated variable. Due to unequal
spacing between sampling days and as indicated by the model fit
criteria a spatial power covariance structure was fitted to the data
[27]. The slice option was used to test for simple effects at each
time point. The denominator degrees of freedom were computed
using the Satterthwaite approximation. For analysis of offspring
haematology, body weight was used as a covariate in the statistical
model. To assess model suitability, data were examined using the
influence diagnostics provided within PROC MIXED in SAS and
by investigation of normality of scaled residuals using the Shapiro-
Wilk test within the UNIVARIATE procedure in SAS. Least
squares means were computed and P values were adjusted for
multiple comparisons using the Tukey-Kramer adjustment. Means
and 95% confidence limits for data which were normalised using
the Box Cox transformation were back-transformed and are
presented on the original scale. Data which were non-normal
(cytokine production) were analysed using the non-parametric
Kolmogorov-Smirnov test within PROC NPAR1WAY [28]. The
exact option was used for non-parametric tests as recommended by
Mundry and Fischer [29]. Non-parametric data is presented as
medians and the 5th and 95th percentiles which were computed
using PROC UNIVARIATE. Significance is reported for P#0.05
and tendencies towards significance are reported for
0.05,P#0.10. For all response criteria, the individual pig was
the experimental unit.
Results
Health of animals
One sow from the control treatment was observed to have a lack
of appetite and fever at day 105 of gestation and received
injectable penicillin between days 105 and 107 of gestation.
Following treatment, the sow made a complete recovery. As all
haematological and immunological parameters investigated for
this sow had similar values to other sows from the same treatment,
data from this sow were not removed from the data set.
Maize and diets
The Bt maize and its non-Bt control counterpart had similar
proximate and amino acid composition [19]. Likewise, amino acid
content and proximate composition were similar for the non-Bt
control and Bt diets used in the present study (Table 1).
Effects of feeding Bt and non-Bt control maize to sows
on sow and offspring haematology
Results of the haematological analysis are presented in Tables 2
and 3 for sows and offspring at birth, respectively. For sow
haematology, no treatment 6 time interaction was observed
(P.0.05; data not shown). WBC# was not different between
treatments at any time point or overall (P.0.05). A time effect was
observed for WBC#, with values decreasing up to day 100 of
gestation and increasing thereafter (P,0.05; data not shown).
Likewise, no treatment differences were observed for LY% overall
or at individual time points. LY% decreased throughout the study
(P,0.05; data not shown). On day 110 of gestation MONO% was
higher in sows on the Bt treatment compared to sows on the
control treatment (P,0.05). However, MONO% was not different
between treatments at any other time point or overall (P.0.05)
and no time effect was observed (P.0.05; data not shown).
GRAN% was lower on day 110 of gestation (P,0.05) and, as a
result, a tendency towards lower overall GRAN% (P=0.06) was
also observed for sows fed Bt maize diets compared to sows fed
non-Bt control maize diets. GRAN% increased throughout the
study (P,0.05; data not shown). LY# was not significantly
different between treatments overall or at any time point (P.0.05).
However, a tendency towards higher LY# on day 110 of gestation
was observed in sows fed Bt maize diets compared to sows fed non-
Bt control maize diets (P=0.09). LY# decreased throughout the
study (P,0.05; data not shown). MONO# was higher on day 110
of gestation (P,0.05) and this lead to a tendency towards a higher
overall MONO# in sows on the Bt treatment compared to the
control treatment (P=0.09). A time effect was also observed for
MONO#, with values decreasing up to day 110 of gestation and
increasing thereafter (P,0.05; data not shown). No treatment
effects were observed for GRAN# (P.0.05); however, values
decreased up to day 110 of gestation and thereafter increased up to
day 28 of lactation (P,0.05; data not shown).
At birth, WBC# was lower (P#0.05) and LY% was higher
(P#0.05) for offspring of Bt maize-fed sows. GRAN% and
GRAN# were lower for offspring of sows fed Bt maize
(P,0.05). MONO# tended to be lower for offspring of sows fed
Bt maize (P=0.07). No treatment effects were observed for
MONO% and LY# in offspring at birth (P.0.05).
Effects of feeding Bt and non-Bt control maize to sows
on immune cell populations from isolated peripheral
blood mononuclear cells
The results from flow cytometric analysis of immune cell
populations present in peripheral blood are presented in Table 4.
No treatment effects were observed for the percentage of white
blood cells. However, a treatment 6 time interaction (P,0.05;
data not shown) and a time effect (P,0.05; data not shown) were
observed, with white blood cells increasing up to day 110 of
gestation and decreasing thereafter. Similar values were observed
for both treatments at all time points and overall for the
percentage of peripheral blood B lymphocytes (P.0.05). B
lymphocyte percentage increased up to day 110 of gestation and
decreased thereafter (P,0.05; data not shown). A treatment 6
time interaction (P,0.05; data not shown) was observed for
monocyte percentage and values increased over time (P,0.05).
Trans-Generational Effects of Bt Maize in Pigs
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On day 28 of lactation the Bt maize-fed sows had lower peripheral
blood monocyte percentages than non-Bt control maize-fed sows
(P,0.05). No treatment effects were observed for the percentages
of CD3+ T lymphocytes and CD4+ T lymphocytes (P.0.05);
however, both increased up to day 110 of gestation and then
decreased up to day 28 of lactation (P,0.05; data not shown).
CD8+ T lymphocyte percentages in peripheral blood were not
affected by feeding Bt maize (P.0.05); however, values decreased
throughout the study (P,0.05; data not shown). A decrease in
CD4+CD8+ T lymphocyte counts was observed for sows on the Bt
treatment compared to sows on the control treatment on day 110
of gestation, day 28 of lactation and overall (P,0.05). Likewise, the
percentage of CD4+CD8+ T lymphocytes in peripheral blood
increased over time (P,0.05; data not shown).
Effects of feeding Bt and non-Bt control maize on
cytokine production from isolated PBMC
Cytokine production data from resting and stimulated PBMC
are presented in Table 5. No treatment effect was observed for IL-
4 and IL-6 production by resting PBMC on day 28 or 110 of
gestation (P.0.05). However, production of both IL-4 and IL-6 by
resting cells increased over time (P,0.05; data not shown). A
tendency towards lower production of IL-8 by resting PBMC was
observed on day 28 and 110 of gestation in sows fed Bt maize
(P=0.10). No time effect was observed for IL-8 (P.0.05; data not
shown). TNF-a production by resting PBMC was not affected on
day 28 of gestation (P.0.05); however, a tendency towards lower
TNF-a production was observed in Bt maize-fed sows on day 110
of gestation (P=0.10). The production of TNF-a by resting
PBMC increased over time (P,0.05; data not shown).
The production of IL-4, IL-6, IL-8 or TNF-a by stimulated
PBMC was not different between treatments at any time point
(P.0.05). However, values for all cytokines increased over time
(P,0.05; data not shown). The production of all cytokines
increased with mitogen stimulation (P,0.05; data not shown).
Cry1Ab protein and transgene detection in blood, faeces
and tissues
The Cry1Ab protein was not detected in the serum of sows at
day 28 and 110 of gestation or at the end of lactation (data not
shown) or in the plasma, heart, kidney, spleen, muscle or brain of
offspring from sows fed either non-Bt control or Bt maize
throughout gestation (data not shown).
The frequency of detection of both transgenic and maize and
porcine endogenous gene fragments is presented in Tables 6 and 7
for sows and offspring at birth, respectively. The 108 bp gene
fragment of the pig-specific sw gene was detected in white blood
cells of all sows from both treatments on day 110 of gestation. The
173 bp fragment of the maize-specific multi-copy rubisco gene was
detected in the white blood cell samples of 2 of 12 sows fed the
non-Bt control maize diet and in 1 of 12 sows fed the Bt maize
diet. In faeces, the same gene fragment was detected in 7 and 5 of
12 sows on the non-Bt control and Bt treatments, respectively. The
213 bp fragment of the maize-specific single-copy sh2 gene was not
detected in white blood cells or faeces of sows from either
treatment. The single-copy 149 or 211 bp fragments of the cry1Ab
transgene were not detected in the blood or faeces of sows from
either treatment group.
In the offspring at birth, the pig-specific sw gene fragment was
detected in all white blood cell samples from the control treatment
and in 11 of 12 white blood cells samples from the Bt treatment.
The sw gene fragment was also detected in all kidney, liver and
muscle samples from both treatment groups. The maize-specific
multi-copy rubisco gene fragment was present in the white blood
cells of two animals from each treatment group and in the muscle
of one animal from each treatment group but was not detected in
any kidney or liver samples analysed. The maize-specific single-
copy sh2 gene fragment was not detected in any of the white blood
cell, kidney, liver or muscle samples from either the control or Bt
treatment group. Neither the 149 bp nor the 211 bp transgene
fragments were detected in white blood cells, kidney, liver or
muscle of offspring at birth from either non-Bt control or Bt
maize-fed sows.
Table 3. Effects of feeding Bt MON810 maize to nulliparous sows during gestation and lactation on offspring haematological
parameters at birth1.
Transformation2 Treatments
Non-Bt control Bt
Mean 95% CI3 Mean 95% CI3 P – value
WBC4,6103/mL none 5.0 3.9–6.1 3.4 2.4–4.5 0.05
Lymphocytes, % 1.5 60.6 47.9–72.2 76.6 65.4–87.0 0.05
Monocytes, % 0.75 15.7 11.7–19.9 13.4 9.6–17.5 0.33
Granulocytes, % 20.25 11.6 6.0–25.3 4.7 2.8–8.8 0.01
Lymphocytes,6103/mL none 2.9 2.2–3.7 2.4 1.7–3.2 0.34
Monocytes,6103/mL 20.25 0.7 0.5–0.9 0.4 0.3–0.6 0.07
Granulocytes,6103/mL 20.5 0.4 0.2–1.0 0.2 0.1–0.3 0.01
1Sows were fed either a non-Bt control or a Bt maize-based diet and blood samples were collected at birth from the 4th live born piglet from each litter (n = 12/
treatment).
2Value of lambda used for Box Cox transformation of data to ensure normal distribution. Means and 95% confidence limits for data which were normalised using the
Box Cox transformation were back transformed and are presented on the original scale.
395% CI –95% confidence interval (the interval that contains the true population mean in 95% of cases).
4WBC – white blood cells.
doi:10.1371/journal.pone.0047851.t003
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Cry1Ab-specific antibody response
Neither Cry1Ab-specific IgA nor IgG were detected in serum
from sows at any sampling point, in colostrum taken from sows
immediately prior to parturition or in plasma from offspring from
either treatment group (data not shown).
Discussion
Most studies that have previously investigated the safety of GM
feed ingredients with respect to animal health have generally
involved only one generation of animals. For this reason multi-
generational studies are needed to fully establish the safety of
feeding GM feed ingredients over multiple generations. To our
knowledge, this is the first study to investigate immune function
and to assess the presence of transgenic products in blood and
tissues of Bt maize-fed pregnant sows and their offspring. Although
there are no data to suggest that the Cry1Ab protein is toxic to
mammals (most likely because they lack specific receptors in the
intestinal tract [5]), nonetheless consumers are concerned about
potential toxicity [2]. However, Cry1Ab occurs in relatively low
quantities in Bt maize (e.g. 0.6 mg/g in this study). Furthermore,
incorporation of Bt maize in complete animal feedstuffs results in
dilution. For these reasons, subtle effects may not be evident unless
multiple health indicators are examined following high-level long-
term exposure [15,30]. Therefore, in the present study, Bt maize
was included at high levels in pig diets (74–87%), and the duration
of the study was extended beyond the 90-day standard recom-
mended by the European Food Safety Authority [31]. In addition,
a wide array of health indicators was assessed in sows and their
offspring to determine the long-term and trans-generational safety
of feeding Bt maize.
Food allergies are characterised by intestinal inflammation and
are associated with diarrhoea and malabsorption [32,33]. How-
ever, no such symptoms were observed in pregnant sows fed Bt
maize [34]. Prolonged allergen exposure increases the magnitude
of an inflammatory response and compromises the integrity of the
intestinal epithelium, thereby allowing the allergen to enter the
circulatory system which may lead to development of a systemic
immune response [32,35,36]. Previous studies have demonstrated
that the quantity of Cry1Ab protein that survives intestinal
digestion is very low and have also confirmed that the Cry1Ab
protein is absent from the blood and organs of livestock fed Bt
maize for extended periods [23,24,37–40]. However, even at low
doses, the Cry1Ab protein has the potential to be allergenic, as, in
general, only minute quantities of allergens are required for an
allergic response in sensitized individuals [36].
In the present study, an increase in the proportion of circulating
T lymphocytes and, more specifically, an increase in CD4+ T or B
lymphocytes, which would be indicative of allergy [36] were not
observed at any time point. The decrease in monocytes and in
immature CD4+CD8+ T lymphocytes from PBMC observed at
day 28 of lactation in response to feeding Bt maize to sows is
unlikely to denote an inflammatory/allergic response. This is
because only an increase of these cell populations associated with
an increase in B and CD4+ T lymphocytes and accompanied by
production of Cry1Ab-specific antibodies would indicate such a
response [33,36]. An increase in the cytokines involved in allergic/
inflammatory responses, such as IL-4, IL-6 IL-8 and TNF-a
[41,42], was also not observed at any time point during the study.
Furthermore, Cry1Ab-specific IgG and IgA were not detected in
response to Bt maize feeding, making it unlikely that treatment
differences observed would indicate an allergic or inflammatory
response. The absence of treatment differences for cytokine
production by stimulated PBMC also indicates that Bt maize-fed
animals are likely to respond in a similar fashion in an in-vivo
challenge situation. These results are in agreement with our
previous findings in pigs fed Bt maize for 31 [23] or 110 days [24],
where no differences in IL-4, IL-6, IL-8 and TNF-a production
were found between treatments in either resting or stimulated
PBMC. In contrast, differences in cytokine production and
Table 4. Effects of feeding Bt MON 810 maize to nulliparous
sows during gestation and lactation on peripheral blood
immune cell populations1,2.
Treatments
Non-Bt control Bt SEM3 P – value
WBC4
d 28 of gestation 42.1 40.5 3.88 0.84
d 110 of gestation 57.1 50.4 3.04 0.28
d 28 of lactation 46.0 52.3 3.07 0.31
Overall 48.4 47.7 3.79 0.90
B lymphocytes
d 28 of gestation 2.8 2.0 0.47 0.42
d 110 of gestation 4.4 4.0 0.35 0.53
d 28 of lactation 3.4 2.9 0.36 0.54
Overall 3.5 3.0 0.36 0.29
Monocytes
d 28 of gestation 9.1 6.8 1.25 0.37
d 110 of gestation 13.5 15.8 0.95 0.25
d 28 of lactation 19.1 13.5 0.95 0.01
Overall 13.9 12.1 0.94 0.17
CD3+ T lymphocytes
d 28 of gestation 51.8 52.0 2.44 0.97
d 110 of gestation 60.6 63.1 1.86 0.52
d 28 of lactation 58.1 60.5 1.83 0.53
Overall 56.8 58.5 1.97 0.57
CD4+ T lymphocytes
d 28 of gestation 7.3 7.4 1.89 0.99
d 110 of gestation 21.9 22.5 1.33 0.82
d 28 of lactation 22.3 19.3 1.35 0.28
Overall 17.2 16.4 1.44 0.70
CD8+ T lymphocytes
d 28 of gestation 38.4 40.0 1.91 0.68
d 110 of gestation 36.1 40.7 1.36 0.11
d 28 of lactation 22.2 24.9 1.38 0.33
Overall 32.2 35.2 1.59 0.20
CD4+CD8+ T lymphocytes
d 28 of gestation 12.9 11.5 1.45 0.56
d 110 of gestation 19.5 15.0 1.15 0.01
d 28 of lactation 19.3 15.4 1.15 0.03
Overall 17.2 14.0 1.17 0.02
1Sows were fed either a non-Bt control or a Bt maize-based diet (n = 12/
treatment).
2Values are given as percentages of the total peripheral blood mononuclear cell
population for all parameters, except the CD4+ CD8+ and CD4+CD8+
lymphocytes which are given as percentages of the CD3+ lymphocytes.
3SEM – standard error of the mean.
4WBC – white blood cells.
doi:10.1371/journal.pone.0047851.t004
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immune cell populations were observed in mice fed Bt maize for
30 or 90 days compared to controls [43]. Although the biological
significance of those findings was questioned by the authors, the
responses observed were believed to be as result of a higher
quantity of the maize allergen zein due to cry1Ab insertion [43].
While this may be true, environment, growing location and
developmental stage have all been shown to have a greater
influence on maize allergens and metabolites than the genetic
modification itself [44–46].
Table 5. Effects of feeding Bt MON810 maize to nulliparous sows during gestation on cytokine production from resting and
stimulated peripheral blood mononuclear cells (pg/mL)1.
Non-Bt control 5–95th percentiles2 Bt 5–95th percentiles2 P - value3
Resting
Day 28 of gestation
IL-4 0.5 0–8.1 0.1 0–5.2 0.77
IL-6 1.2 0–14.1 0.7 0–3.2 0.52
IL-8 1666.8 66.6–10795.5 1150.3 278.7–1506.4 0.10
TNF-a 10.5 0.4–71.7 8.5 3.0–36.2 0.54
Day 110 of gestation
IL-4 108.0 0–1049.4 72.8 0–121.9 0.24
IL-6 19.9 0–1184.6 22.8 0–45.5 0.85
IL-8 3691.7 0–21749.2 1233.0 0–4127.1 0.10
TNF-a 222.1 0–25555.2 105.1 16.2–319.2 0.10
Stimulated
Day 28 of gestation
IL-4 12.8 0–127.2 16.9 1.3–45.1 0.87
IL-6 38.5 9.3–203.3 34.3 14.3–198.7 0.99
IL-8 6527.7 1742.0–13819.8 6801.2 1703.5–18474.8 0.87
TNF-a 9331.6 3056.7–28898.4 11725.9 3519.3–23946.0 0.87
Day 110 of gestation
IL-4 447.0 0–1227.4 457.9 300.4–656.5 0.87
IL-6 400.3 0–753.7 475.9 260.1–672.5 0.87
IL-8 11757.8 0–36328.5 11882.7 8010.8–15270.9 0.54
TNF-a 18765.3 133.2–130654.7 18185.9 12167.8–22784.5 0.54
1Sows were fed either a non-Bt control or a Bt maize-based diet (n = 12/treatment).
2The 5th percentile is larger than 5% of the values and the 95th percentile is larger than 95% of the values.
3Computed on untransformed data using the Kolmogorov-Smirnov non-parametric test within PROC NPAR1WAY in SAS.
doi:10.1371/journal.pone.0047851.t005
Table 6. Detection of endogenous maize and porcine gene fragments and transgene fragments in blood and faeces of sows fed
non-Bt control or Bt maize-based diets during gestation and lactation1.
Treatments
Non-Bt control Bt Non-Bt control Bt
Gene (fragment length)
White blood
cells Faeces
Endogenous
sw – pig-specific (108 bp) 12 12 NA2 NA2
rubisco – multicopy maize-specific (173 bp) 2 1 7 5
sh2 – single copy maize-specific (213 bp) 0 0 0 0
Transgenic (single copy)
cry1Ab (149 bp) 0 0 0 0
cry1Ab (211 bp) 0 0 0 0
1Number of samples out of 12 that tested positive for the gene fragment of interest. One sample was tested per sow (n = 12 sows/treatment).
2Not assessed.
doi:10.1371/journal.pone.0047851.t006
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An inflammatory response is also characterised by an increased
white blood cell count and increased granulocytes and monocytes
(which are both white blood cell types), representing the innate
immune response. This is then followed by an increase in
lymphocytes during the development of the adaptive immune
response [36]. On the contrary, in the present study, the
proportion of monocytes within the PBMC decreased on day 28
of lactation in response to feeding Bt maize, although this was not
reflected in the findings for monocytes within whole blood. In fact,
an increase in monocytes was observed during haematological
analysis of Bt maize-fed sows during gestation. This could be
explained by the higher body weight observed in these sows in the
second half of gestation [34], as monocyte recruitment and
increased cytokine production are known to be associated with an
increase in body weight [47]. However, no differences in fat
deposition or cytokine production were observed between
treatments. Furthermore, monocyte counts remained within the
normal range for pigs and this difference did not persist up to day
28 of lactation. While an increase in granulocyte percentage could
be indicative of inflammation, in the present study we observed
only a decrease in granulocyte percentage in whole blood for Bt
maize-fed sows on day 110 of gestation, which was mirrored in the
blood of offspring at birth. A lower abundance of the potentially
pathogenic Proteobacteria observed in faeces of Bt maize-fed sows
(Buzoianu et al., unpublished) may be the cause of the lower
granulocytes and tendencies towards lower IL-8 and TNF-a
observed in these sows, as Proteobacteria have been positively
correlated with increased blood granulocytes and cytokine
production [48,49]. Illness was not the reason for the treatment
differences in immune cell populations observed in sows, as all
animals were in good health, except for one sow in which immune
parameters were unaffected (as outlined above). Likewise, the
variability between animals on the same treatment was small, as
evidenced by the confidence intervals. While no differences were
observed for total white blood cell counts in sows fed Bt maize, a
lower WBC# was observed in their offspring at birth. Only an
increase in WBC# is associated with an allergic or inflammatory
response. However, a higher LY% was observed at birth in the
blood of offspring of Bt maize-fed sows and lymphocytes are a
subset of white blood cells, but this was not mirrored in sows. The
absence of the Cry1Ab protein in sow or foetal blood indicates that
there was no contact between the Cry1Ab and the foetal immune
system which was also evidenced by the absence of Cry1Ab-
specific antibodies in blood of either sows or their offspring.
Furthermore, an increase in spleen weight which is known to
accompany a systemic immune response [50] was not observed in
these piglets at birth [34]. An additional study using littermates of
piglets from the present study found no increase in spleen weight
later in life (,143 days of age) and an absence of health
abnormalities (Buzoianu et al, unpublished). Therefore, while
treatment differences were observed in offspring at birth for
certain haematological parameters in this study, they are not
believed to indicate an allergic/inflammatory response to Bt maize
ingestion by the sows. Furthermore, the values in sows generally
remained within the normal range reported for pigs [50].
However, in offspring, lymphocyte and monocyte percentages
were higher and granulocyte count and percentage were lower
than the normal ranges [50,51]. Stress is known to have a major
influence on haematological parameters [50] and as these samples
were taken immediately after birth, a time of great stress for the
piglet, this may help to explain the deviations from the normal
ranges.
Differences in immune response have previously been observed
in sheep following Bt maize consumption for three years [52] and
in mice after 30 and 90 days of Bt maize consumption [43].
Similar to results from our study, biological significance of these
findings was also questioned by the authors and the inconsistency
in results between studies is likely to be due to the use of different
animal models. However, while neither of the above studies
investigated Cry1Ab-specific antibody production, our results, as
well as those of Adel-Patient et al. [53] for mice, indicate that no
antibodies to the Cry1Ab protein are produced as a result of oral
exposure to Bt MON810 maize.
Although present in the diet, both transgenic and native single-
copy gene fragments (cry1Ab and sh2) were degraded along the
gastrointestinal tract (GIT), as they were not detected in the faeces
of sows or in the organs of the offspring. However, the multicopy
rubisco maize gene was present in sow faeces and was detected at
low frequency in the blood and in the muscle and blood of
offspring, but did not reach the organs. Extensive DNA
degradation was expected, as high DNase activity is found along
the porcine GIT [18,54]. In agreement with our previous results
[23,24] and those of others [37,40,52,55], the present study
confirms that DNA from single-copy genes is degraded along the
Table 7. Detection of endogenous maize and porcine gene fragments and transgene fragments in blood and organs of offspring
from sows fed non-Bt control or Bt maize-based diets during gestation and lactation1,2.
Treatments
Non-Bt control Bt Non-Bt control Bt Non-Bt control Bt Non-Bt control Bt
Gene (fragment length)
White blood
cells Kidney Liver Muscle
Endogenous
sw – pig specific (108 bp) 12 11 12 12 12 12 12 12
rubisco – multicopy maize specific (173 bp) 2 2 0 0 0 0 1 1
sh2 – single copy maize specific (213 bp) 0 0 0 0 0 0 0 0
Transgenic (single copy)
cry1Ab (149 bp) 0 0 0 0 0 0 0 0
cry1Ab (211 bp) 0 0 0 0 0 0 0 0
1Samples were collected at birth from the 4th live born piglet from each litter.
2Number of samples out of 12 that tested positive for the gene fragment of interest. One sample was tested per piglet (n = 12 piglets/treatment).
doi:10.1371/journal.pone.0047851.t007
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GIT of livestock and does not reach the organs. There is no clear
explanation why Mazza et al. [56] detected plant genes (both
endogenous and transgenic) in the organs of 35 kg pigs, but
discrepancies may be related to age/weight of the pigs, maturity of
the intestine, dietary inclusion rate and time since the last meal.
While DNA transfer to tissues and across the placenta has been
confirmed in the present study, the frequency of detection appears
to be more related to the number of copies of the gene of interest
than to its endogenous or transgenic nature. Our results confirm
that there are no differences in degradability and uptake of
transgenic DNA compared to that of native plant DNA. In
addition, incorporation and stable expression of transgenic DNA
into the host genome and detrimental effects on the host as a
consequence have not been demonstrated.
The fact that responses to Bt maize consumption are
inconsistent across different species highlights inter-species vari-
ability and calls into question the relevance of these findings to
humans. Therefore, the biological relevance of findings in the
animal model should first be addressed before attempting to
extrapolate results to humans. Furthermore, as biological processes
are complex and interrelated in nature, investigating a wide range
of parameters simultaneously allows for a more definitive
assessment of biological relevance. Ruminants and rodents are
frequently used as models for humans; however, they are not
without shortcomings [57,58]. As porcine intestinal physiology and
microbiota as well as aspects of immune function are similar to
that of humans [16,17,57], pigs are increasingly used as models for
human immune response and even as candidates for xenotrans-
plantation [32,59,60]. Therefore, our results in pigs, which
demonstrate a lack of biologically significant effects on immune
function as a result of feeding Bt maize could potentially be
considered of more relevance to humans than findings from
studies which use less appropriate animal models.
Overall, this study provides additional safety data which
demonstrates that Bt maize is unlikely to pose any risk to pig
health, even following long-term consumption and a similar
response could be expected in humans. While differences in a
limited number of immune parameters were observed in breeding
pigs and their offspring in response to maternal intake of Bt maize,
we consider these differences insufficient to indicate consistent
activation of the innate immune system. Likewise, activation of the
adaptive immune system (Th2 profile/allergy or Th1 profile/
inflammation) was not observed in the present study. Furthermore,
cytokine production was neither significantly different between
treatments nor indicative of an immune response to Bt maize
consumption. As neither the Cry1Ab protein nor antibodies
specific to it were detected in the blood of either sows or offspring,
these results support the conclusion that feeding Bt maize to
pregnant sows during gestation and lactation does not adversely
affect maternal or foetal immune function.
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